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Abstract. 
 
In 
 
Xenopus
 
 
 
laevis
 
 oocytes, overexpression of 
calreticulin suppresses inositol 1,4,5-trisphosphate-
 
induced Ca
 
2
 
1
 
 
 
oscillations in a manner consistent with 
inhibition of Ca
 
2
 
1
 
 uptake into the endoplasmic reticu-
lum. Here we report that the alternatively spliced iso-
forms of the sarcoendoplasmic reticulum Ca
 
2
 
1
 
-ATPase 
(SERCA)2 gene display differential Ca
 
2
 
1
 
 wave proper-
ties and sensitivity to modulation by calreticulin. We 
demonstrate by glucosidase inhibition and site-directed 
mutagenesis that a putative glycosylated residue 
(N1036) in SERCA2b is critical in determining both the 
selective targeting of calreticulin to SERCA2b and iso-
form functional differences. Calreticulin belongs to a 
novel class of lectin ER chaperones that modulate im-
mature protein folding. In addition to this role, we sug-
gest that these chaperones dynamically modulate the 
conformation of mature glycoproteins, thereby affect-
ing their function.
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C
 
alreticulin
 
, calnexin, and calmegin represent a
novel class of lectin chaperones that modulate
protein folding in the ER, ensuring that immature
polypeptides achieve their correct mature folding confor-
mation (Bergeron et al., 1994; Hammond et al., 1994;
Hammond and Helenius, 1994; Helenius, 1994; Nigam
et al., 1994; Nauseef et al., 1995; Williams, 1995; Helenius
et al., 1997). In brief, the molecular events associated with
the modulation of protein folding involve the recognition
and binding of calreticulin and calnexin to the monogluco-
sylated form of misfolded glycoproteins in the ER lumen
(Ou et al., 1993; Hammond et al., 1994; Peterson et al.,
1995; Otteken and Moss, 1996; Rodan et al., 1996; Zapun
et al., 1997). After chaperone dissociation, polypeptides
that have not achieved their mature conformation are re-
glucosylated by the action of the UDP-glucosyl trans-
ferase, which acts as the folding sensor (Hebert et al.,
1995; Sousa and Parodi, 1995; Ware et al., 1995). This re-
glucosylation allows cyclic association and dissociation of
the chaperones from their targets (Helenius et al., 1997).
Ligand-mediated activation of the inositol 1,4,5-tris-
phosphate receptor (IP
 
3
 
R)
 
1
 
 causes release of Ca
 
2
 
1
 
 from
intracellular stores (Berridge, 1993; Putney and Bird, 1993;
Pozzan et al., 1994; Bezprozvanny and Ehrlich, 1995;
Clapham, 1995; Furuichi and Mikoshiba, 1995). At inter-
mediate IP
 
3
 
 concentrations, Ca
 
2
 
1
 
 
 
release causes oscilla-
tions and waves in 
 
Xenopus laevis
 
 oocytes (Parker and
Yao, 1991; DeLisle and Welsch, 1992; Lechleiter and
Clapham, 1992) and other cells (Cornell-Bell et al., 1990;
Boitano et al., 1992; Dani et al., 1992; Mahoney et al.,
1993; Rooney and Thomas, 1993; Nathanson et al., 1995;
Robb-Gaspers and Thomas, 1995; Simpson and Russell,
1996). The cyclic nature of these oscillations is possible be-
cause of the operation of two fundamental processes.
First, the probability of opening the IP
 
3
 
-bound IP
 
3
 
R is
governed by cytosolic Ca
 
2
 
1
 
 such that at low Ca
 
2
 
1
 
 concen-
trations, the probability of opening is increased, but at
high Ca
 
2
 
1
 
 concentrations channel inactivation occurs (Iino,
1990; Parker and Ivorra, 1990; Bezprozvanny et al., 1991;
Finch et al., 1991). Second, Ca
 
2
 
1
 
 sequestration from the cy-
tosol by Ca
 
2
 
1
 
-sensitive ATPases can remove the inhibitory
effect of high cytosolic Ca
 
2
 
1
 
 on the IP
 
3
 
R (MacLennan et
al., 1997). Consistent with this fact, we have previously
demonstrated that overexpression of sarcoendoplasmic
reticulum Ca
 
2
 
1
 
-ATPases (SERCAs) 1 and 2b causes a
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two- to threefold increase in the frequency of Ca
 
2
 
1
 
 
 
waves
(Camacho and Lechleiter, 1993; Camacho and Lechleiter,
1995). Three genes encode a family of structurally related
Ca
 
2
 
1
 
-ATPases (MacLennan et al., 1985; Brandl et al.,
1986; Gunteski-Hamblin et al., 1988; Lytton and MacLen-
nan, 1988; Burk et al., 1989). By overexpressing SERCA
isoforms in COS cells, Lytton and coworkers demon-
strated that all SERCAs are activated by a rise in cytosolic
Ca
 
2
 
1
 
,
 
 
 
and that isoforms differ in their sensitivity to Ca
 
2
 
1
 
(Lytton et al., 1992). SERCA3, a selectively expressed iso-
form (Wu et al., 1995), is the least sensitive to Ca
 
2
 
1
 
 (
 
K
 
d
 
 
 
z
 
1
 
m
 
M), while SERCA1, the skeletal muscle isoform (Wu et
al., 1995), has an intermediate sensitivity (
 
K
 
d
 
 
 
z
 
400 nM). The
SERCA2 gene produces two alternatively spliced products
that differ in their Ca
 
2
 
1
 
 sensitivity, turnover rates of Ca
 
2
 
1
 
transport, and ATP hydrolysis (Lytton et al., 1992; Ver-
boomen et al., 1992; Verboomen et al., 1994). SERCA2a,
the cardiac isoform (Wu et al., 1995), has an intermediate
sensitivity to cytosolic Ca
 
2
 
1
 
 (
 
K
 
d
 
 
 
z
 
400 nM), and is func-
tionally indistinguishable from SERCA1 (Lytton et al.,
1992). In contrast, the SERCA2b isoform, which is expressed
in all nonmuscle cells (Wu et al., 1995), has the highest
sensitivity to Ca
 
2
 
1
 
 (
 
K
 
d
 
 
 
z
 
200 nM) and the lowest transport
capacity of all SERCAs (Lytton et al., 1992). In the present
study, we report functional differences in terms of Ca
 
2
 
1
 
wave properties when either SERCA2a or SERCA2b iso-
forms are overexpressed. Unlike SERCA2a, SERCA2b has
an additional 46 amino acids at its COOH terminus
(Gunteski-Hamblin et al., 1988). Thus, unlike all other
members of this family of Ca
 
2
 
1
 
-ATPases, SERCA2b has
an additional eleventh transmembrane segment that places
its COOH terminus in the ER lumen (Bayle et al., 1995). In
this COOH terminus, asparagine residue N1036 forms part
of a glycosylation consensus signal. Recent evidence suggests
that this residue may be glycosylated (Bayle et al., 1995).
We have previously demonstrated that calreticulin over-
expression in 
 
Xenopus laevis 
 
oocytes modulates IP
 
3
 
-
mediated Ca
 
2
 
1
 
 release. This modulation is characterized
by a sustained elevation in cytosolic Ca
 
2
 
1
 
 without repeti-
tive oscillations in Ca
 
2
 
1
 
 release (Camacho and Lechleiter,
1995). Even in those oocytes that display Ca
 
2
 
1
 
 oscilla-
tions, the latter are of lower amplitude and frequency (Ca-
macho and Lechleiter, 1995). Modulation of Ca
 
2
 
1
 
 release
by calreticulin survives despite deletion of the high-capac-
ity/low-affinity Ca
 
2
 
1
 
 binding domain (
 
D
 
C mutant), sug-
gesting that high-capacity Ca
 
2
 
1
 
 buffering by calreticulin
is not responsible for inhibition of Ca
 
2
 
1
 
 oscillations. The
 
D
 
C mutant contains both the N- and P-domains of cal-
reticulin (Michalak et al., 1992; Camacho and Lechleiter,
1995). The proline-rich P-domain, which is responsible for
lectin activity (Krause and Michalak, 1997), is shared with
calnexin and calmegin (Ohsako et al., 1994; Tjoelker et
al., 1994; Watanabe et al., 1994). Here we test the hypothe-
sis that calreticulin inhibits IP
 
3
 
-mediated Ca
 
2
 
1
 
 oscilla-
tions by interacting with the putative glycosylated residue
at the COOH terminus of SERCA2b, thereby modulating
the folding state, and thus Ca
 
2
 
1
 
 uptake by SERCA2b.
Since SERCA2a lacks this luminal COOH terminus, we
test the hypothesis that differences in Ca
 
2
 
1
 
 uptake be-
tween the two isoforms are due to an interaction with cal-
reticulin. By pharmacologically inhibiting glucosidases, we
implicate the lectin activity of calreticulin in modulating
Ca
 
2
 
1
 
 pump activity of SERCA2b. Furthermore, by site-
directed mutagenesis we demonstrate that the residue
N1036 of SERCA2b is critical in determining the functional
differences between the products of the SERCA2 gene.
 
Materials and Methods
 
Expression Vector Construction 
 
All cDNAs were subcloned between the 5
 
9
 
 and 3
 
9
 
 untranslated regions of 
 
Xe-
nopus
 
 
 
laevis
 
 
 
b
 
-globin as previously described (Camacho and Lechleiter,
1995). To overexpress SERCA2a, we used PCR to amplify the full open read-
ing frame from the cDNA encoding rat SERCA2a (Gunteski-Hamblin et al.,
1988; clone RS 8-17, gift of G. Shull, University of Cincinnati College of
Medicine, Department of Microbiology and Molecular Genetics). The
forward primer in the PCR reaction had the sequence 5
 
9
 
-ATGCGGATC-
CGCCATGGAGAACGCTCACACAAAGACCG-3
 
9
 
 and encoded for a
BamHI site at the NH
 
2
 
 terminus, while the reverse primer with the sequence
5
 
9
 
-ATCGAAGCTTCGGTTACTCCAGTATTGCAGGC-3
 
9
 
 incorporated
a HindIII site at the 3
 
9
 
 end of the SERCA2a-encoding cDNA. After ampli-
fication, the PCR product was gel-isolated, digested with BamHI and HindII,
and subcloned into the vector pGEM-HE Not. Because the plasmid RS 8-17
encoding SERCA2a had a missing adenosine (nucleotide 1490) that would
create an open reading frame shift at the NH
 
2
 
 terminus, the fragment Bam-
HI
 
®
 
EcoRI was substituted with the identical fragment from SERCA2b.
Since the cDNAs encoding SERCA2a and SERCA2b are identical until nu-
cleotide 3,484, the resulting plasmid pHN-SERCA2a contains the cDNA en-
coding SERCA2a between the 5
 
9
 
 UT and the 3
 
9
 
UT of 
 
Xenopus laevis
 
b
 
-globin. DNA sequencing was used to corroborate the addition of the
missing adenosine nucleotide. The construction of 
 
Xenopus
 
 expression ve-
ctors for 
 
D
 
C and SERCA2b has previously been described (Camacho and
Lechleiter, 1995).
A general-purpose 
 
Xenopus
 
 expression vector encoding a fusion of GFP
with any desired cDNA was made as follows: on the first round of construc-
tion, the EcoRI fragment from pRSETB-GFP S65T (gift of R. Tsien, Uni-
versity of California San Diego, Department of Cellular and Molecular Med-
icine, La Jolla, CA) was subcloned into plasmid pGEM-HE-Not digested
with EcoRI treated with calf intestinal phosphatase (Boehringer Mannheim
Corp., Indianapolis, IN) to dephosphorylate the ends. The resulting plasmid
pHNb-GFP-S65T contains the GFP (S65T) mutant and multiple cloning
sites (MCS) from pRSETB. In the second round of construction, we used
this template to PCR-amplify GFP-S65T without a stop codon. The forward
primer used in the PCR reaction had the sequence 5
 
9
 
-ATTCGAGCTCGG-
TACCCAGCTTGCTTGTTC-3
 
9
 
, is complementary to the 5
 
9
 
 UT of 
 
Xenopus
laevis
 
 
 
b
 
 globin, and also contains a SstI and KpnI restriction site of
pGEM-HE-Not. The reverse primer had the sequence 5
 
9
 
-GAGCTC-
GAGCTCGGATCCTTTGTATAGTTCATCCATGCC-3
 
9
 
,
 
 
 
and encodes
the last seven amino acids at the COOH terminus of GFP (except the stop
codon) followed by the BamHI, SstI, and XhoI restriction sites from the
MCS of pRSETB. The amplified PCR fragment GFP-S65T without the stop
codon was digested with EcoRI, gel-isolated, and subcloned into plasmid
pGEM-HE-Not. This vector called pHN-GFP-S65T(
 
D
 
TAA) was sequenced
to corroborate deletion of the stop codon, and was used to prepare the fusion
constructs of GFP (S65T) at the NH
 
2
 
 terminus of SERCA2a, SERCA2b,
and the SERCA2bN1036A. A BamHI fragment from pHN-GFP-
S65T(
 
D
 
TAA) containing the GFP (S65T) minus the stop codon was sub-
cloned into pHN-GFP-SERCA2a previously digested with BamHI, and was
treated with calf intestinal phosphatase. Thus, the cDNA encoding GFP-
S65T(
 
D
 
TAA) would be fused in frame with the SERCA2a cDNA. The anal-
ogous procedure was followed in the construction of pHN-GFP(S65T)-
SERCA2b as well as pHN-GFP (S65T)-S2bN1036A.
 
In Vitro Transcriptions and Oocyte Protocols
 
Synthetic mRNA was prepared as previously described (Camacho and
Lechleiter, 1995). In brief, plasmids were linearized with NotI (restriction
enzymes from GIBCO BRL, Gaithersburg, MD) except for plasmid pHN-
 
D
 
C, which was linearized with NheI. Transcription from the T7 promoter
was carried out using reagents from the Megascript™ high-yield transcrip-
tion kit and capped with m
 
7
 
G(5
 
9
 
)ppp(5
 
0
 
) (both from Ambion, Austin,
TX). All synthetic mRNAs were resuspended at a concentration of 1.5–
2.0 
 
m
 
g/
 
m
 
l and stored in aliquots of 3 
 
m
 
l at 
 
2
 
80
 
8
 
C until used. Stage VI–
defolliculated oocytes were injected with a 50-nl bolus of mRNA using a
standard positive pressure injector (Nanoject; Drummond Scientific Co., 
John et al. 
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Broomall, PA). After mRNA injection, oocytes were cultured for 5–7 d
until Ca
 
2
 
1
 
 imaging was performed. The culture media contained 50%
L-15 Media (GIBCO BRL) supplemented with antibiotics, and was
changed daily. Unhealthy oocytes were also discarded daily.
 
Western Blot Analysis
 
Oocyte extracts used in Western blots were prepared from pools of 10 oo-
cytes as previously described (Camacho and Lechleiter, 1995). The final
pellet of each extract was resuspended in 50 ml of 1% SDS per oocyte
equivalent, and was stored frozen in aliquots of one oocyte equivalent
each. One oocyte equivalent of each fraction was loaded on an SDS gel,
stained with Coomassie blue, and scanned on a UMAX Powerlook II
scanner. Two invariant adjacent protein bands of z40 kD that appear in
each extract were used as densitometric standards. The average of all den-
sitometric readings was used to normalize the sample volume to load on
SDS PAGE gels. To detect the DC mutant, samples were run on a 12%
gel, and to detect the SERCA2 and GFP-tagged SERCA2 proteins, the
samples were run on 8% gels by SDS-PAGE. To visualize the SERCA an-
tigen, the membranes were probed with the polyclonal rabbit anti-
SERCA antibody (C-4 Ab in Fig. 1 c and N1 Ab in Figs. 2 b and 7 a; both
antibodies were a gift from J. Lytton, University of Calgary Health Sci-
ences Centre, Department of Biochemistry and Molecular Biology, Cal-
gary, Alberta, Canada). To detect the DC mutant of calreticulin (see Figs.
5 b and 6 d), oocyte fractions were probed with a primary rabbit anti-
KDEL Ab that recognizes the COOH-terminal six amino acids of calreti-
culin (gift of M. Michalak, University of Alberta, Department of Bio-
chemistry, Edmonton, Alberta, Canada). Note that this mutant contains
the last six amino acids of calreticulin, including the KDEL ER retention
signal, and thus it can be detected with this antibody (Camacho and Lech-
leiter, 1995). Alkaline phosphatase–conjugated secondary antibodies were
used in all Western blots (Jackson ImmunoResearch Laboratories, Inc.,
West Grove, PA), and colorimetric detection was accomplished by NBT/
BCIP (NitroBlue Tetrazolium/5-Bromo-4-Chloro-3-Indolyl Phosphate;
Promega Corp., Madison, WI).
Confocal Imaging of Intracellular Ca21
Ca21 wave activity was imaged as previously described (Camacho and
Lechleiter, 1995). In brief, oocytes were injected with either Calcium
Green I or Calcium Orange (Molecular Probes, Inc., Eugene, OR) as indi-
cated 30 –60 min before each experiment. The fluorescent indicator was
delivered by positive pressure injection in a 50-nl bolus and designed to
reach z12.5 mM final concentration assuming a 1:20 dilution of a 1-ml oo-
cyte volume. Unless otherwise stated in the figure legend, images were ac-
quired with a MRC 600UV confocal laser scanning microscope (Bio-Rad
Laboratories, Hercules, CA) at zoom 1.5 attached to a Diaphot inverted
microscope with a 103 (0.5 NA) UVfluor objective lens (Nikon, Inc.,
Melville, NY) at 0.5-s intervals using Time Course/Ratiometric Software
(TCSM; Bio-Rad Laboratories). The confocal aperture was set at its larg-
est diameter. Images were analyzed with ANALYZE software (Mayo
Clinic/Foundation, Rochester, MN) on a Sun Sparc2 or a Silicon Graphics
O2 workstation. Ca21 increases were reported as DF/F, which represents
(Fpeak 2 Frest) / Frest. Ca21 wave activity was induced by injecting a 50-nl
bolus of 6 mM IP3 (z300 nM final; Calbiochem-Novabiochem Corp., La
Jolla, CA). All images were acquired in extracellular medium containing
96 mM NaCl, 2 mM KCl, 2 mM MgCl2, 5 mM Hepes (pH 7.5; GIBCO
BRL), and 1 mM EGTA (Sigma Chemical Co.) without extracellular
Ca21. GFP fluorescence in Figs. 2 c and 7 b was acquired using a Noran
OZ confocal laser scanning microscope using a 603 water immersion ob-
jective (1.2 NA) at zoom 1.0.
Immunofluorescence
Oocytes were saved individually for immunofluorescence to detect ex-
pression and targeting of DC and SERCAs. Oocytes were fixed in 4%
paraformaldehyde, 3% sucrose solution for 2 h at 48C. To remove fixative,
the oocytes were washed twice in 20% sucrose, 0.1 M phosphate buffer
followed by incubation with shaking for 2 h at 48C. Oocytes were embed-
ded in acrylamide (Hausen and Dreyer, 1991) as previously described
(Camacho and Lechleiter, 1995), frozen in a dry ice–EtOH bath, and sec-
tioned in 20-mm slices at 2208C. Oocyte slices were mounted on glass
slides, and nonspecific binding was blocked with a 2% blocking reagent
(Boehringer Mannheim Corp., Indianapolis, IN) and 10% horse serum in
13 TBS solution. Slices were incubated for 1–2 h with a rabbit anti–
human calreticulin polyclonal Ab (1:30 dilution, antibody PA3-900; Affin-
ity Bioreagents, Golden, CO). After washing the primary antibody three
times in 13 TBST, oocyte slices were incubated with lissamine-rhodamine
anti-rabbit secondary antibody (1:30 dilution, Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA). The secondary antibody was washed
again as described above, and the slides were mounted in media contain-
ing buffered (pH 8.5) polyvinyl alcohol (Mowiol™; Calbiochem-Novabio-
chem Corp.) prepared according to Osborn and Weber (1982). Anti-fad-
ing agent (n-propyl gallate; Sigma Chemical Co.) was added to the
mounting medium at a concentration of 20 g/liter (Longing et al., 1993).
To label SERCAs 2a, 2b, and SERCA2bN1036A mutant, we used a rabbit
polyclonal Ab C-4 that recognizes all rat SERCA pumps (gift of J. Lyt-
ton). The oocyte slices were incubated with C-4 Ab for 60 min at 1:500 di-
lution in 1% blocking reagent and 10% Donkey serum (Jackson Immu-
noResearch Laboratories). After four washes of 3 min each in TBST,
incubation with FITC-conjugated goat anti–rabbit IgG (H1L; Jackson
ImmunoResearch Laboratories) was performed for 60 min at a 1:17 dilu-
tion. After washing four times for 3 min each in 13 TBST, a second block-
ing step was added (1% blocking reagent, 10% donkey serum) for 30 min.
After a final wash cycle, the slices were mounted as described above.
Stained sections were imaged with a MRC 600UV confocal microscope
(Bio-Rad Laboratories) adapted to a Diaphot 200 inverted microscope
and a 1003 (1.3NA) oil immersion objective (Nikon, Inc.) using a fluoros-
cein and rhodamine filter set (Bio-Rad’s T1 / T2A filter cubes), and were
combined with an argon/krypton laser (Coherent).
Statistical Analysis
Statistical significance was determined by using a one-tailed Student’s
t-test or a Chi squared test as appropriate.
Results
Functional Differences Between SERCA2a
and SERCA2b
To compare the modulation of IP3-mediated Ca21 release
by SERCA2a and SERCA2b, we overexpressed each iso-
form by injecting synthetic mRNAs (50 nl, 2 mg/ml) into
Xenopus laevis oocytes (cDNAs encoding rat SERCAs;
Gunteski-Hamblin et al., 1988). Confocal imaging of Ca21
wave activity was performed 5–7 d later as previously de-
scribed (Camacho and Lechleiter, 1995). In control oo-
cytes (H2O replacing mRNA), IP3 injection (z300 nM fi-
nal) initiates a tidal wave of Ca21 release that envelopes
the entire oocyte, and is followed by low-frequency oscilla-
tions (Camacho and Lechleiter, 1993; Camacho and
Lechleiter, 1995). In contrast, similar injections of IP3 into
oocytes overexpressing SERCA2 isoforms result in high-
frequency Ca21 waves (shorter period between waves)
without an initial Ca21 tide. Confocal images of intracellu-
lar Ca21 release for two oocytes overexpressing either
SERCA2a or SERCA2b obtained at low magnification
are shown in Fig. 1 a (103 objective, top). Ca21 wave pro-
files in SERCA2b-overexpressing oocytes (n 5 30) are
characterized by broad wave widths and sharply delin-
eated wave fronts. In contrast, the wave profiles in
SERCA2a-overexpressing oocytes (n 5 19) have shorter
wave widths, and the leading wave fronts are poorly delin-
eated. These differences in individual Ca21 wave charac-
teristics are more clearly observed at a higher magnifica-
tion (403 objective) in oocytes overexpressing either
SERCA2a (n 5 4) or SERCA2b (n 5 4; Fig. 1 a, bottom).
Immunofluorescence images with a SERCA-specific anti-
body shows that both Ca21 ATPases are targeted to the
same yolk-free ER corridors in the oocyte (Fig. 1 b). The
immunofluorescence pattern is identical in SERCA2a and
SERCA2b-overexpressing oocytes. A control oocyte (H2OThe Journal of Cell Biology, Volume 142, 1998 966
replacing mRNA injection) also demonstrates a similar
pattern of low-intensity cross-reactivity of the anti-rat
SERCA antibody with the endogenous Xenopus Ca21-
ATPases (Fig. 1 b, lower left). Western blot analysis re-
veals that the SERCA2 isoforms are overexpressed at
roughly equivalent levels (Fig. 1 c). Since quantitation of
expression levels by Western blotting is not very precise,
we incorporated a fluorescent tag into either SERCA2a or
SERCA2b so that Ca21 wave properties could be com-
pared in oocytes expressing equivalent levels of exogenous
pumps. To this end we labeled each SERCA2 isoform with
the green fluorescent protein (GFP) S65T mutant (Heim
et al., 1995). GFP tagging at the NH2 terminus was the pre-
ferred strategy since the sequence differences between the
two isoforms reside at the COOH terminus (Fig. 2 a). In
these fusion constructs and according to accepted topolog-
ical maps of SERCA proteins (Clarke et al., 1990; Bayle
et al., 1995), GFP is expected to face the cytosol. The re-
sulting fusion constructs were expressed in the oocyte by
injecting synthetic mRNAs encoding GFP-SERCA2a and
GFP-SERCA2b. Extracts from oocytes overexpressing ei-
ther the wild-type (SERCA2a and SERCA2b) isoforms or
the fusion proteins (GFP-SERCA2a and GFP-SERCA2b)
were prepared and analyzed by Western blot probing with
an antibody that recognizes the SERCA2 antigens. As ex-
Figure 1. Overexpression of
SERCA2a and SERCA2b
reveals functional differences
between isoforms in IP3-
induced repetitive Ca21 wave
activity. (a) Comparison of the
IP3 (z300 nM final)-induced
Ca21 response in a SERCA2a
(left) and a SERCA2b (right)-
overexpressing oocyte. In the
top two panels the confocal
images are 745 mm 3 745 mm
and are imaged at low magni-
fication (103 objective; bar,
z100  mm). In the bottom two
panels, two different oocytes
are confocally imaged at
higher magnification (403
objective; bar, z20 mm) and
the confocal images are 240
mm 3 180 mm. Individual im-
ages of Ca21 wave activity
were taken at peak activity.
(b) Confocal immunofluores-
cence of SERCA2a and
SERCA2b. The top panels
show immunofluorescence
obtained with a primary anti-
body to rat SERCAs gener-
ated in rabbit (C-4, gift of J.
Lytton) and a secondary
FITC-conjugated goat anti–
rabbit antibody (Jackson Im-
munoResearch Laborato-
ries). The bottom panels are
controls. The left panel
shows immunofluorescence
of a control oocyte (not injected with SERCA2 message) reveal-
ing endogenous levels of cross-reactivity with the native Xenopus
oocyte SERCA2b protein. The right panel shows control immuno-
fluorescence omitting the primary antibody. Bar, z10 mm. (c)
Western blot of SERCA2 protein levels in either control oocytes
injected with H2O (lane 1) or oocytes overexpressing SERCA2b
(lane  2) and SERCA2a (lane 3) mRNAs. SERCA2 products
were detected by probing with the same C-4 primary antibody
used in b. One oocyte equivalent was loaded per lane and run on
an 8% SDS PAGE gel. Molecular size markers (in kD) are indi-
cated on the left (Hi range; Bio-Rad Laboratories).
Figure 2. Overexpression of GFP-SERCA2 fusion constructs re-
veals functional differences in SERCA2a and SERCA2b. (a)
Cartoon view of the fusion constructs used to tag SERCA iso-
forms at the NH2 terminus with the S65T increased fluorescence
mutant of GFP. (b) Western blot analysis demonstrates overex-
pression of GFP-SERCA2 fusion products detected by probing
the membrane with a polyclonal anti-SERCA2 antibody that was
raised in rabbit against a recombinant His-tagged fragment en-
compassing most of the cytoplasmic loop between M4 and M5
from rat SERCA2 (N1, gift of J. Lytton). Wild-type SERCA2a
and SERCA2b (lanes 1 and 3, respectively) migrated z27 kD be-
low fusion protein products contained in extracts from oocytes
overexpressing GFP-SERCA2a and GFP-SERCA2b (lanes 2 and
4, respectively). Oocyte extracts from control oocytes (H2O re-
placing mRNA) were run on lane 5. Molecular size markers (in
kD) are indicated on the left (Kaleidoscope; Bio-Rad Laborato-
ries). (c) High magnification confocal images of GFP fluores-
cence in oocytes overexpressing GFP-SERCA2a and GFP-
SERCA2b fusion proteins (left and middle, respectively). Note
that fluorescence is confined to the ER corridors between yolk
platelets. A control oocyte overexpressing cytosolic GFP is
shown (right). In this oocyte, fluorescence is more diffuse. Images
are 52 mm 3 36 mm, and were acquired with an OZ confocal laser
scanning microscope (Noran Instruments, Middleton, WI). The
oocytes were excited at 488 nm and imaged with a 603 water im-
mersion objective. Bar, z10 mm.John et al. Calreticulin Modulation of SERCA2 Isoforms 967
pected, GFP fusion products migrate differentially with an
apparent Mr z27 kD larger than for unmodified proteins,
and the mobility differences of the two isoforms are re-
tained (Fig. 2 b). Confocal images acquired at high magni-
fication (603 objective) demonstrate a reticular pattern of
GFP fluorescence in oocytes overexpressing either GFP-
SERCA2a or GFP-SERCA2b, but not in oocytes overex-
pressing cytosolic GFP (Fig. 2 c). This immunofluores-
cence pattern of the GFP-tagged pumps is identical to that
of the unmodified SERCA2a and SERCA2b shown in Fig.
1 b, indicating that GFP fusion does not interfere with tar-
geting to the ER compartment. Low-magnification images
of GFP fluorescence (103 objective) were used to measure
overexpression levels of tagged SERCA2a and SERCA2b.
Unlike control oocytes (H2O instead of mRNA) that do
not emit fluorescence when excited at 488 nm, oocytes
overexpressing either GFP-SERCA2a or GFP-SERCA2b
do fluoresce (Fig. 3 a). IP3-mediated Ca21 wave activity
was imaged with the fluorescent indicator Ca21 Orange
(Molecular Probes, Inc.) in the two oocytes that had
matching GFP fluorescence levels (Fig. 3 b). Comparison
of these two oocytes shows that the GFP-SERCA2b–over-
expressing oocytes have longer periods between waves,
and exhibit wider wave widths than oocytes overexpress-
ing the GFP-SERCA2a fusion product. Data analysis from
oocytes that could be matched for GFP fluorescence levels
(Fig. 3 c) also shows longer periods between waves and
wave widths in GFP-SERCA2b (n 5 13) than in GFP-
SERCA2a-expressing oocytes (n 5 10). These data sug-
gest that the GFP-tagged pumps behaved like the wild-
type isoforms, and allowed us to demonstrate conclusively
that the functional differences between the two pumps
seen in Fig. 1 a cannot be attributed to differences in ex-
pression levels. Rather, differences in Ca21 uptake proper-
ties between SERCA2a and SERCA2b reflect the intrinsic
differences in their primary structure (amino acid sequence).
Differential Effects of Calreticulin on
SERCA2 Isoforms
We have previously demonstrated that injecting IP3 in Xe-
nopus laevis oocytes coexpressing calreticulin and SERCA2b
results in a sustained release of Ca21 without repetitive
Ca21 oscillations (Camacho and Lechleiter, 1995). This ef-
fect of calreticulin survives deletion of the high-capacity
Ca21- binding domain (DC mutant), and therefore it is not
due to the high Ca21 storage capacity of calreticulin in the
ER stores. The inhibition of Ca21 oscillations by calreticu-
lin (or DC) overexpression is consistent with a modulation
of SERCA activity to slow Ca21 uptake (Camacho and
Lechleiter, 1995). Because DC contains the proline-rich
P-domain of calreticulin shared by the other members of
Figure 3. GFP-SERCA2 isoforms retain the characteristics of
their respective unmodified proteins and at equivalent levels of
expression exhibit different Ca21 wave characteristics. (a) Fluo-
rescence images in GFP-SERCA2a (left) and GFP-SERCA2b
(middle) overexpressing oocytes that have been matched for
equivalent levels of GFP fluorescence intensity. GFP fluores-
cence (745 mm 3 530 mm) was excited at 488 nm. Note that under
these imaging conditions, fluorescence levels in control oocytes
(injected with H2O instead of GFP-SERCA2 mRNA) are not de-
tectable. For quantitation of overexpression levels of GFP fusion
proteins, fluorescence values were measured from images ob-
tained at a low magnification (103 objective; bar, z100 mm). (b)
Spatio-temporal patterns (left) of Ca21 release induced by injec-
tion of IP3 (z300 nM final) in oocytes as labeled. In this experi-
ment, Ca21 Orange (Molecular Probes, Inc.) was used as indica-
tor of Ca21 wave activity so that GFP fluorescence and Ca21
wave activity could be observed in the same oocyte. GFP(S65T)
absorption and emission maxima in the visible spectrum occur at
490 and 509 nm, respectively, while for Ca21 Orange these are
590 nm and 650 nm, respectively. Thus, for the imaging parame-
ters used, Ca21 Orange fluorescence does not overlap with GFP
fluorescence emission. Each temporal stack contains 400 images
taken at 0.5-s intervals. A single image (530 mm 3 745 mm) of
Ca21 wave activity is shown at the indicated time (right). (c) At
equivalent levels of GFP fluorescence, the Ca21 wave properties
are different for oocytes overexpressing GFP-SERCA2a (gray
bars, n 5 13) and GFP-SERCA2b (black bars, n 5 10). Histo-
gram of GFP fluorescence (left) shows fluorescence intensity
measurements in arbitrary units. Histogram of Ca21 wave period
(middle) and Ca21 wave decay time (right) measure each of these
parameters from the time course of the average fluorescence in-
tensity of a 5 3 5 pixel area. Note that GFP-SERCA2a-overex-
pressing oocytes display a higher Ca21 wave frequency (i.e.,
shorter periods) than the GFP-SERCA2b-overexpressing oo-
cytes. * Indicates a statistically significant difference at P , 0.005.The Journal of Cell Biology, Volume 142, 1998 968
this class of ER chaperones (Ohsako et al., 1994; Tjoelker
et al., 1994; Watanabe et al., 1994), and because lectin ac-
tivity resides in the P-domain (Krause and Michalak,
1997), we tested whether DC modulation of SERCA2b
was responsible for the decreased rate of Ca21 transport
characteristic of this pump (Lytton et al., 1992). Further-
more, since SERCA2a does not have a glycosylation motif
facing the lumen of the ER, we also decided to test
whether the functional differences between the two iso-
forms are due to a lack of interaction of calreticulin with
SERCA2a. To this end, we coexpressed DC with
SERCA2b or with SERCA2a (Fig. 4). A high percentage
of SERCA2b-overexpressing oocytes exhibited robust
high-frequency IP3-mediated Ca21 oscillations (94%; n 5
32; Fig. 4 a). The number of oocytes showing repetitive
Ca21 activity was significantly reduced when SERCA2b
Figure 4. DC inhibits Ca21 oscillations when coexpressed with
SERCA2b, but not when coexpressed with SERCA2a. (a and b)
Comparison of the IP3 (z300 nM)-induced Ca21 wave activity
in a SERCA2b-overexpressing oocyte with the Ca21 wave activ-
ity of a SERCA2b 1 DC-coexpressing oocyte. (c and d) Compar-
ison of the IP3 ( z 300 nM)-induced Ca21 wave activity in a
SERCA2a-overexpressing oocyte with the Ca21 wave activity of
a SERCA2a 1 DC-coexpressing oocyte. Individual confocal im-
ages (745 mm 3 745 mm) of Ca21 wave activity were taken at the
indicated times. The bottom trace in each panel represents the
change in fluorescence (DF/F) shown as a function of time for a
5 3 5 pixel area (white square in the first panel of each image).
Figure 5. DC inhibition of repetitive Ca21 waves and reversal of
the DC effect by glucosidase inhibitors. (a) The percent of oo-
cytes exhibiting repetitive Ca21 oscillations is significantly re-
duced in oocytes coexpressing DC with SERCA2b (black bars),
but not in oocytes coexpressing DC with SERCA2a (gray bars;
**P , 0.01, Chi-squared test). Of those oocytes that did display
repetitive Ca21 oscillations, the interwave period (middle histo-
gram) and decay time (right histogram) were significantly increased
in oocytes coexpressing DC with SERCA2b when compared with
control oocytes overexpressing SERCA2b alone (*P , 0.005). No
significant differences were found between oocytes coexpressing
DC with SERCA2a as compared with control oocytes overex-
pressing SERCA2a alone in either interwave period or in decay
time of individual waves. Note that there is a change in scale val-
ues for the ordinate in histograms of wave period and decay time
with respect to Fig. 3 c. The larger scale in this figure reflects the
longer period and longer decay time of Ca21 waves in SERCA2b 1
DC-overexpressing oocytes. (b) Western blot analysis demon-
strates overexpression of the DC mutant of CRT in fractions from
oocytes coexpressing this calreticulin mutant with SERCA2a
(lane  1) and SERCA2b (lane 2). Oocyte extracts from control oo-
cytes (H2O replacing mRNA) were run on lane 3. The membrane
was probed with a primary anti-CRT KDEL Ab that recognizes
the last six amino acids at the COOH terminus of rabbit CRT
(gift of Michalak). (c) Glucosidase inhibition antagonizes the ef-
fects of DC overexpression on oscillatory Ca21 waves. Period be-
tween waves in SERCA2b 1 DC-overexpressing oocytes is signifi-
cantly decreased (n 5 13) in oocytes injected with 1 mM final DNJ
(Toronto Research Chemicals, North York, Ontario, Canada)
when compared with uninjected SERCA2b 1 DC control oocytes
(n 5 18). **Indicates statistical significance at P , 0.025. In the
same groups of oocytes, decay time of individual Ca21 waves is also
reduced, although the differences are not statistically significant.John et al. Calreticulin Modulation of SERCA2 Isoforms 969
was coexpressed with DC (66%, n 5 32, P , 0.01). In the
remaining oocytes (34%), injections of IP3 caused sus-
tained release of Ca21 without repetitive Ca21 waves (Fig.
4 b). Detailed analysis of Ca21 waves revealed that even in
those SERCA2b 1 DC-coexpressing oocytes that had re-
petitive Ca21 waves, the interwave periods were significantly
longer (P , 0.005), and wave widths were significantly
broader (P , 0.005) than those oocytes overexpressing
SERCA2b alone (Fig. 5 a). In the majority of SERCA2a-
overexpressing oocytes (95%, n 5 20), injections of IP3
caused high-frequency Ca21 oscillations such as those ob-
served in the oocyte shown in Fig. 4 a. In contrast to the in-
hibition of Ca21 oscillations seen in oocytes coexpressing
SERCA2b 1 DC, all SERCA2a 1 DC–overexpressing oo-
cytes tested (100%, n520) exhibited high-frequency Ca21
oscillations (Fig. 4 d). Detailed analysis revealed that there
were no statistically significant differences in Ca21 wave
properties between SERCA2a and SERCA2a 1 DC–
overexpressing oocytes (Fig. 5 a). Western blot analysis re-
vealed that the DC mutant was coexpressed with either
SERCA2a or SERCA2b in this set of experiments, sug-
gesting that the lack of modulation of SERCA2a by DC
cannot be attributed to a lack of DC expression (Fig. 5 b).
Correct targeting of DC to the ER was confirmed by con-
focal immunofluorescence performed on oocyte slices
probed with an anti-calreticulin Ab as previously de-
scribed (Camacho and Lechleiter, 1995; data not shown).
Together these results indicate that the differential Ca21
transport by the SERCA2 isoforms must be due to the
presence of the luminal-facing COOH terminus extension
of SERCA2b, conferring susceptibility of SERCA2b to
modulation by calreticulin.
Residue N1036 of SERCA2b is Implicated in the 
Inhibitiory Effect of Calreticulin
Deoxynojirimycin (DNJ) is a specific inhibitor of glucosi-
dases I and II, and prevents calreticulin and calnexin bind-
ing to monoglucosylated target residues (Hebert et al.,
1995; Peterson et al., 1995). If modulation of SERCA2b
Ca21 uptake by calreticulin results from a lectin effect,
then this glucosidase inhibitor should antagonize the ef-
fects of DC overexpression. To test this hypothesis, we in-
jected DNJ into oocytes that were overexpressing
SERCA2b  1 DC (n 5 18) 30–60 min before imaging. DNJ
injection (z1 mM final) resulted in significantly (P ,
0.025) decreased interwave periods in SERCA2b 1 DC–
overexpressing oocytes (n 5 13; Fig. 5 c). A similar trend
was observed in terms of a decrease in the decay time of
individual waves in these oocytes. No significant differ-
ences were observed in the percent of oocytes displaying
repetitive Ca21 wave activity between control and DNJ-
injected oocytes.
Unlike SERCA2a, SERCA2b has a potential glycosy-
lated residue (N1036) at the COOH terminus (Fig. 6 a). If
the sustained Ca21 release and inhibition of oscillatory
Ca21 waves is due to an interaction of calreticulin (or DC)
with this SERCA2b residue, then site-directed mutagene-
sis to an unreactive alanine (SERCA2bN1036A mutant)
should remove this potential site of calreticulin interac-
tion. Consequently, when coexpressed with SERCA2b-
N1036A,  DC should no longer have an effect on repetitive
Ca21 wave activity. To test this hypothesis, we overex-
pressed either SERCA2bN1036A by itself, or coexpressed
it with DC (SERCA2bN1036A 1 DC oocytes). Overexpres-
sion of SERCA2bN1036A alone resulted in high-fre-
quency Ca21 oscillations in all oocytes tested (n 5 23; Fig.
Figure 6. Site-directed mutagenesis of SERCA2b residue N1036
creates a protein that is no longer responsive to DC coexpression,
and that resembles SERCA2a. (a) Amino acid sequence compar-
ison between the COOH terminus of SERCA2a and SERCA2b.
The eleventh transmembrane segment of SERCA2b is shown
(hatched). The consensus N-linked glycosylation motif is under-
lined, and the mutated residue N1036A is indicated in bold. (b)
Comparison of Ca21 wave activity in two oocytes overexpressing
SERCA2bN1036A (top) or SERCA2bN1036A 1 DC (bottom).
(c) The left histogram shows percent of oocytes exhibiting repeti-
tive Ca21 oscillations when SERCA2bN1036A is expressed alone
or with DC. Of those oocytes that displayed repetitive Ca21 oscil-
lations, no significant differences were found in either interwave
period (middle histogram) or in decay time (right histogram) be-
tween oocytes coexpressing DC with SERCA2bN1036A and con-
trol oocytes overexpressing SERCA2bN1036A alone. These re-
sults are similar to those observed for SERCA2a and SERCA2a
1 DC-overexpressing oocytes (see Fig. 4 b). (d) Western blot
analysis demonstrates overexpression of DC in fractions from
SERCA2bN1036A 1 DC oocytes (lane 1). No detectable CRT
product was observed in extracts from control oocytes (H2O re-
placing mRNA) (lane 2). The membrane was probed with the
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6 b). As predicted, repetitive Ca21 activity was not inhib-
ited when DC was coexpressed with SERCA2bN1036A (n 5
22), suggesting that this mutation removed the site of in-
teraction of calreticulin with SERCA2b (Fig. 6, b and c).
Detection of the DC mutant protein product in
SERCA2bN1036A  1 DC-overexpressing oocytes was cor-
roborated by Western blotting and probing with an anti-
KDEL Ab to the COOH terminus of calreticulin (Fig. 6
d). Together, these results implicate a role for calreticulin
in the modulation of Ca21 uptake via SERCA2b, but not
SERCA2a, and suggest that the residue N1036 in
SERCA2b is a putative target of lectin activity of this
chaperone.
The Single Amino Acid Substitution (N1036A) Confers
SERCA2a-like Functional Properties to SERCA2b
To compare the properties of SERCA2bN1036A with
those of the wild-type SERCA2 isoforms on Ca21 wave ac-
tivity accurately, we tagged SERCA2bN1036A with GFP
at the NH2 terminus under conditions of equivalent levels
of expression. A Western blot probed with an anti-
SERCA2 antibody demonstrated that SERCA2bN1036A
migrated differentially from GFP-SERCA2bN1036A pro-
tein as expected (Fig. 7 a). GFP fluorescence imaging at
high magnification (603 objective) of a GFP-SERCA2b-
N1036A-overexpressing oocyte (Fig. 7 b) demonstrated
that the fusion protein was targeted to the same ER com-
partment as shown for both wild-type (Fig. 1 b) and GFP-
tagged SERCA2 isoforms (Fig. 2 c). GFP fluorescence in-
tensity of equal magnitude to that in the oocytes shown in
Fig. 3 a was measured at low magnification (103 objec-
tive) for a GFP-SERCA2bN1036A oocyte shown in Fig. 7
b, allowing us to compare the Ca21 wave properties of this
oocyte directly (Fig. 7 c) with those of the GFP-SERCA2a
and GFP-SERCA2b oocytes shown in Fig. 3 b. We carried
out detailed analyses of oocytes that were matched in GFP
flluorescence intensity in the study (Table I). Remarkably,
Ca21 wave activity normalized for GFP fluorescence re-
vealed that the single amino acid mutation in SERCA2b
(N1036A) yielded a Ca21 ATPase with uptake properties
indistinguishable from those of SERCA2a. Furthermore,
there was no inhibitory effect of DC when it was coex-
pressed with either SERCA2a or SERCA2bN1036A (Figs.
4 b and 6 c). Together, these data indicate that the func-
tional differences between SERCA2a and SERCA2b on
Ca21 wave activity reported here and elsewhere (Lytton et
al., 1992; Verboomen et al., 1992; Verboomen et al., 1994)
can be attributed to the presence of the luminal gly-
cosylated residue on SERCA2b that is absent in
SERCA2a.
Discussion
On the basis of sequence homology at the COOH termi-
nus with calsequestrin, calreticulin was originally de-
scribed as a Ca21-binding protein buffering Ca21 in the ER
lumen (Fliegel et al., 1989; Treves et al., 1990; Michalak et al.,
1992; Krause and Michalak, 1997). Several investigators
have reported that calreticulin affects Ca21 signaling in
multiple cell systems (Treves et al., 1990; Liu et al., 1994;
Bastianutto et al., 1995; Coppolino et al., 1997). The ma-
jority of these reports have discussed the role of calreticu-
lin in terms of its ability to bind Ca21 with low affinity but
high capacity. Our work, however, uncovers a distinct and
separate pathway that points towards a calreticulin-medi-
ated modulation of Ca21 signaling, possibly via its known
lectin properties. IP3-mediated Ca21 release in Xenopus
Figure 7. Residue N1036 is critical in determining the functional
differences between SERCA2 isoforms. (a) Differential migra-
tion patterns between SERCA2bN1036A (lane 1) vs. GFP-
SERCA2bN1036A (lane 2) on a Western blot probed with the
same N1 anti-SERCA2 Ab from Fig. 2 b. Fractions from control
oocytes (H2O replacing mRNA) were run on lane 3. (b) Confocal
images of GFP fluorescence intensity at high resolution (603 ob-
jective; 52 mm 3 36 mm) and at low resolution (103 objective;
745 mm 3 530 mm) in a GFP-SERCA2bN1036A oocyte matched
for GFP fluorescence intensity with the oocytes shown in Fig. 3 a.
(c) Spatiotemporal stack (left) of Ca21 wave activity from the
GFP-SERCA2bN1036A overexpressing oocyte in b. Confocal
image of Ca21 wave activity at the indicated time (right). Imaging
parameters were similar to those described in Fig. 3 b.
Table I. Ca21 Wave Activity in GFP-SERCA2 Fusion Proteins
n
GFP
fluorescence
Oocytes with
repetitive waves‡ Period Decay time
%s t 1/2
GFP-SERCA2a* 10 80.98 6 8.10 100 3.01 6 0.30 0.916 0.09
GFP-SERCA2b* 13 81.51 6 6.27 100 3.70 6 0.28§ 1.16 6 0.09i¶
GFP-SERCA2bN1036A 8 81.82 6 10.23 100 3.38 6 0.42 0.74 6 0.09
Mean 6 SEM. n, total number of oocytes in each category. % is the percent of n. *These data have been plotted in Fig. 3 C. ‡Oocytes with repetitive waves of Ca21 release only.
§SERCA2b is not equivalent to SERCA2a (P , 0.005). iSERCA2b is not equivalent to SERCA2a (P , 0.005). ¶SERCA2b is not equivalent to SERCA2bN1036A (P , 0.005).John et al. Calreticulin Modulation of SERCA2 Isoforms 971
laevis oocytes overexpressing wild-type calreticulin is
characterized by a sustained elevation in intracellular Ca21
without concurrent oscillations in Ca21 release (Camacho
and Lechleiter, 1995). Deletion of the high-capacity Ca21
storage domain (DC mutant) does not affect the ability of
calreticulin to modulate Ca21 release (Camacho and
Lechleiter, 1995), indicating that the mechanism of action
of calreticulin cannot be attributed to Ca21 buffering in
the ER lumen. Furthermore, the inhibitory effect of cal-
reticulin (or DC) on Ca21 waves suggests two possible
mechanisms of action: either calreticulin interacts with the
IP3R to prolong Ca21 release or it interacts with the Ca21-
ATPase to inhibit Ca21 uptake. These two mechanisms
need not be mutually exclusive, as both types of interac-
tion may occur. In this report we focused our studies on
the functional interaction of calreticulin with the Ca21-
ATPases.
We demonstrated that there are functional differences
in Ca21 signaling by SERCA2a and SERCA2b isoforms.
These differences are consistent with the kinetic parame-
ters of SERCA2a and SERCA2b reported by other
groups (Lytton et al., 1992; Verboomen et al., 1992; Ver-
boomen et al., 1994). SERCA2b was reported to have the
lowest transport capacity of all Ca21-ATPases (Lytton et al.,
1992). In agreement with this result, we observed that the
width of individual Ca21 waves as well as the period be-
tween waves is larger in SERCA2b-overexpressing oocytes
(as compared with SERCA2a-overexpressing oocytes). In
addition, Lytton and coworkers reported that SERCA2b
has the highest Ca21 sensitivity. Thus, SERCA2b-overex-
pressing oocytes have more sharply delineated Ca21 wave-
fronts since the pump begins to uptake Ca21 almost simul-
taneously as it is released by the IP3R. The differences in
Ca21 wave properties between the alternatively spliced
products of the SERCA2 gene must be attributed to the
additional eleventh transmembrane segment and luminal
COOH terminus of SERCA2b. Unlike the other members
of the SERCA family, SERCA2b has a glycosylation motif
in the ER lumen (Gunteski-Hamblin et al., 1988; Bayle et
al., 1995). If the functional differences between SERCA2b
and SERCA2a are due to an interaction of calreticulin (or
DC) with the putative glycosylated residue of SERCA2b,
then coexpression of DC with SERCA2a should not in-
hibit repetitive Ca21 waves. Indeed, we found that this was
the case in all oocytes overexpressing SERCA2a 1 DC.
These data implicate asparagine1036 of SERCA2b as a
site of possible lectin interaction with calreticulin. This
conclusion is supported by three additional findings. First,
it is the DC mutant where the lectin activity of the calreti-
culin resides (Krause and Michalak, 1997) that causes inhi-
bition of repetitive Ca21 waves when coexpressed with
SERCA2b. Second, glucosidase inhibition by DNJ inhibits
the  DC effect when the DC was coexpressed with
SERCA2b. Third, site-directed mutagenesis of N1036 to
an unreactive alanine abrogates the DC effect in oocytes
overexpressing SERCA2bN1036A 1 DC. These results
suggest that a lectin interaction of calreticulin is responsible
for inhibition of Ca21 oscillations, and provide compelling
evidence that N1036 is functional and glycosylated. Inter-
estingly, a previous report demonstrated that progressive
deletion mutants of the COOH terminus of SERCA2b, all
of which lacked the N1036 residue, confer upon SERCA2b
Ca21 transport properties of SERCA2a (Verboomen et
al., 1994). These results can now be understood in light of
our data, which clearly demonstrate that residue N1036 is
responsible for the functional differences between the two
isoforms. By tagging each pump with GFP at the NH2 ter-
minus, we were able to match individual oocytes for levels
of expression based on GFP fluorescence intensity. The
isoform differences displayed in Fig. 3 clearly demonstrate
that at equivalent levels of expression, SERCA2b modu-
lates Ca21 wave activity differently from SERCA2a, and
more interestingly, the modulation by the SERCA2b-
N1036 mutant is indistinguishable from that of SERCA2a
(Fig. 7 c and Table I). Site-directed mutagenesis did not
appear to cause misfolding defects of the SERCA2bN1036
mutant since (a) the extent and appropriate SDS-PAGE
migration of SERCA2bN1036A was observed by Western
blot analysis; (b) high-resolution imaging demonstrated
ER targeting similar to that of wild-type SERCA2 pro-
teins; and (c) physiological evidence demonstrated full
functionality of the protein. These observations are consis-
tent with the fact that other transporters fold normally, are
targeted properly, and are not misfolded without the
cotranslational addition of N-linked oligosaccharide
(Groves and Tanner, 1994). We suggest that the N1036
residue is critical in determining the transport characteris-
tics of SERCA2b. Furthermore, our data suggest that a
functional interaction between calreticulin and this resi-
due determines the lower transport capacity of this Ca21-
ATPase. In support of this result, SERCA2b and calreti-
culin are found to colocalize in Xenopus laevis oocytes
(Parys et al., 1994; Camacho and Lechleiter, 1995) and in
other cell types (Takei et al., 1992; Parys et al., 1994;
Stendahl et al., 1994; Lievremont et al., 1996; Rooney and
Meldolesi, 1996; Vanlingen et al., 1997).
Association of either calreticulin or calnexin with
thioredoxins has been reported (Nigam et al., 1994; Baksh
et al., 1995; Oliver et al., 1997), in some instances in a
Ca21- and/or ATP-dependent manner (Nigam et al., 1994;
Baksh et al., 1995). This result suggests that modulation of
protein folding by calreticulin or calnexin involves intra-
or interdisulfide bond formation. In this context, it is inter-
esting to note that the SERCA2 isoforms possess a con-
served pair of cysteine residues in their longest luminal
facing loop (Gunteski-Hamblin et al., 1988), which is in
close proximity to the COOH terminus (Stokes et al.,
1994). Thus, it is likely that the DC-induced inhibition of
Ca21 oscillations in oocytes overexpressing SERCA2b in-
volves modulation of the redox state of the thiol groups
facing the lumen of this Ca21-ATPase. According to this
hypothetical scenario, the initial event would involve bind-
ing to the target protein in the monoglucosylated state by
calreticulin, followed by recruitment of other proteins, in-
cluding thioredoxins, in a complex that modulates folding
of the target. Two current models have been proposed re-
garding the chaperone activity of calreticulin and calnexin.
One model assumes that binding to the monoglucosylated
carbohydrate group is sufficent for interaction with the
target (Helenius, 1997). The second model suggests that in
addition to the lectin interaction, calreticulin and calnexin
may have direct protein–protein interactions with their
target, thereby fulfilling their role as traditional chaperones
(Williams, 1995). In our experiments, a lectin interaction isThe Journal of Cell Biology, Volume 142, 1998 972
suggested by the demonstration that the N-glycosylation
site in SERCA2b is necessary for calreticulin-mediated in-
hibition of Ca21 oscillations. At the present time we can-
not rule out the possibility that after initial binding to the
monoglucosylated residue, the P-domain interacts directly
with a motif in SERCA2b to suppress IP3-mediated Ca21
oscillations. Overexpression of calreticulin or any other
deletion mutant of calreticulin that we have tested, includ-
ing the DC mutant, does not interfere with the extent of
coexpression of SERCA2 pumps (Camacho and Lechlei-
ter, 1995), suggesting that the chaperone does not induce
misfolding and degradation of SERCA2b. Optimal levels
of expression of SERCA2b (as indicated by the appear-
ance of high-frequency Ca21 waves) appear only 7–9 d af-
ter mRNA injection. This observation together with data
from other laboratories (Gill et al., 1996) in which the for-
mation of functional Ca21 pools after thapsigargin treat-
ment requires 3–6 h, suggests that the synthesis of new
SERCA protein is very slow. Thus, we suggest the possi-
bility that calreticulin not only functions as a lectin chaper-
one that modulates folding of integral membrane glyco-
proteins during protein processing and maturation, but, as
is the case of SERCA2b described here, it may also dy-
namically modulate the conformation of mature proteins
with immediate functional consequences. This interpreta-
tion is further supported by the ability of the glucosidase
inhibitor DNJ to reverse effects of the DC mutant coex-
pression with SERCA2b on the modulation of Ca21 wave
activity. Since the DNJ treatment was acute (30-min expo-
sure only), our data are consistent with an action of CRT
on the monoglucosylated form of a fully mature protein.
In conclusion, the results presented here provide a new
conceptual framework to understand how ER luminal
proteins control Ca21 release and uptake. Based on the
lectin properties of calreticulin, we suggest that this novel
class of chaperones can dynamically modulate the confor-
mation of integral membrane glycoproteins, thereby af-
fecting their function.
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